Scott Requadt

2021

In 2021, Scott Requadt earned a total compensation of $748.1K as President, Chief Executive Officer and Director at Tourmaline Bio, a 78% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$219,474
Salary$515,480
Other$13,103
Total$748,057

Requadt received $515.5K in salary, accounting for 69% of the total pay in 2021.

Requadt also received $219.5K in non-equity incentive plan and $13.1K in other compensation.

Rankings

In 2021, Scott Requadt's compensation ranked 9,691st out of 12,415 executives tracked by ExecPay. In other words, Requadt earned more than 21.9% of executives.

ClassificationRankingPercentile
All
9,691
out of 12,415
22nd
Division
Manufacturing
4,294
out of 5,505
22nd
Major group
Chemicals And Allied Products
1,904
out of 2,375
20th
Industry group
Drugs
1,690
out of 2,096
19th
Industry
Biological Products, Except Diagnostic Substances
368
out of 449
18th
Source: SEC filing on April 29, 2022.

Requadt's colleagues

We found two more compensation records of executives who worked with Scott Requadt at Tourmaline Bio in 2021.

2021

Nancy Krieger

Tourmaline Bio

Chief Medical Officer

2021

Suzanne Ildstad

Tourmaline Bio

Chief Scientific Officer

News

You may also like